CLINICAL_TRIALS
research
· 2011-04-06
Clinical Trial Update: Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
Summary
A clinical trial entry examining how RUNX1 mutations contribute to the etiology of acute myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hillel Yaffe Medical Center | Conditions: Acute Myeloid Leukemia | Status: UNKNOWN